Shares of Health Care sector company Illumina moved -0.9% today, and are now trading at a price of $138.28. The large-cap stock's daily volume was 1,878,696 compared to its average volume of 2,603,630. The S&P 500 index returned a -1.0% performance.
Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is based in San Diego and has 11,500 full time employees. Its market capitalization is $21,958,862,848.
21 analysts are following Illumina and have set target prices ranging from $50.0 to $258.0 per share. On average, they have given the company a rating of buy. At today's prices, ILMN is trading 1.83% away from its average analyst target price of $135.79 per share.
Over the last year, ILMN shares have gone down by -29.3%, which represents a difference of -52.3% when compared to the S&P 500. The stock's 52 week high is $238.55 per share and its 52 week low is $89.0. Although Illumina's average free cash flow over the last 6 years has been $644.0 Million, they have been decreasing at an average rate of -23.5%. For this reason, investors may continue to shun the stock.
Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
---|---|---|---|---|
2023 | 392,000 | 286,000 | 106,000 | -68.55 |
2022 | 545,000 | 208,000 | 337,000 | -62.18 |
2021 | 1,080,000 | 189,000 | 891,000 | 5.82 |
2020 | 1,051,000 | 209,000 | 842,000 | 0.0 |
2019 | 1,051,000 | 209,000 | 842,000 | -0.47 |
2018 | 1,142,000 | 296,000 | 846,000 |